Ironwood Pharma ( (IRWD) ) has released a notification of late filing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Ironwood Pharmaceuticals, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to the identification of material weaknesses in the company’s internal controls, which have rendered its financial reporting ineffective. As a result, additional time is needed to complete management’s assessment and finalize the report. The company expects to file the Form 10-K within fifteen calendar days following the original due date. Despite the delay, Ironwood Pharmaceuticals does not anticipate any significant changes in its financial results from the previous year. The company remains committed to resolving the internal control issues and ensuring compliance with regulatory requirements, as indicated by the signature of Gregory Martini, Senior Vice President and Chief Financial Officer.
More about Ironwood Pharma
YTD Price Performance: -62.82%
Average Trading Volume: 3,185,256
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $257.6M
See more insights into IRWD stock on TipRanks’ Stock Analysis page.